openPR Logo
Press release

Upcoming in 2015: VISION PHARMA – Leading trade fair for Pharma, Medical Devices Industries and Biotechnology – AND MORE

08-08-2014 07:08 PM CET | Health & Medicine

Press release from: MicroMol GmbH

Upcoming in 2015: VISION PHARMA – Leading trade fair

VISION PHARMA is the future of trade fair visits. it covers not only the complete value-adding chain in PHARMA (Research & Development, Production, GxP, Quality Management, Product Safety, Plants, Equipment and Machines, Analyses and Laboratory), but provides platforms for lectures, product presentations, application performances, round tables and expert discussion panels.

VISION PHARMA correlates user and contractor, industry and science, requirement and solution.

VISION PHARMA attracts exhibitors and researchers from all over Europe.
More than 8.000 visitors in 2014 took advantage from the one-stop-event, visiting booths, hearing lectures, discussing with experts and all for free! An enlightened opportunity to add elected new contacts to your customer base.

VISION PHARMA exhibitors only need to send their Graphic Charts for the Lounge scenery consisting of white high-class booths and bars, all in elegant design. One price enables participation for all assistants, giving lectures, presenting products, using VIP-lounges, inviting 1.000 visitors for free, getting excellent catering, joining two evening events and networking with everyone… is all-inclusive

A MUST! Just ask me: ab.dreusch@micromol.com

MicroMol was founded in 1996 and has developed into one of Europe´s leading players in custom research and development in the fields of microbiology, molecular biology, cell biology and biochemistry.
MicroMol is working for pharma, medical device industries, cosmetics and food and offers validations, qualifications and routine detection experiments. besides, MicroMol develops products or proceeds its own research.
MicroMol is privately owned and has actually 28 associates.

MicroMol GmbH
Hedwigstr. 2-8
76199 Karlsruhe
Germany
Fon: +49 721 941 521 3
Fax: +49 721 941 521 4
www.micromol.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Upcoming in 2015: VISION PHARMA – Leading trade fair for Pharma, Medical Devices Industries and Biotechnology – AND MORE here

News-ID: 293004 • Views:

More Releases from MicroMol GmbH

MicroMols 17025 accreditation successful
MicroMols 17025 accreditation successful
Friday, the 6th of February 2009 - The auditors of the german accreditation body for chemistry (DACH) were working the whole day long to put the microbiological Lab and MicroMols documentation to the acid test. Now, at the final discussion of the audit MicroMols CEO Dr. Andreas Dreusch and the complete staff were waiting on the closing result: “For sure we´re a little bit nervous”, reveals MicroMols QMB Ginette Berth,
The most beautiful booth at Biotechnica
The most beautiful booth at Biotechnica
Molecular biology in golden frames At the Biotechnica 2007 MicroMol´s "The fine art if life science" was presented for the first time to the public - spectacularly! The booth in hall 8 was presented almost like an exhibition in the exhibition and was an insiders tip from the first day. "We never saw science like this!" or "That´s absolutely different! Fantastic!" were reactions to the idea to exhibit the high-ranking products,

More Releases for PHARMA

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the